{"created":"2020-08-30T20:06:20.862390+00:00","id":3182,"links":{},"metadata":{"_buckets":{"deposit":"96243ca8-26cf-44aa-a5ca-cbf21efa3718"},"_deposit":{"id":"3182","owners":[],"pid":{"revision_id":0,"type":"recid","value":"3182"},"status":"published"},"_oai":{"id":"oai:meral.edu.mm:recid/3182","sets":["1582963366982:1596631630241"]},"communities":["um1"],"item_1583103067471":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_1551255647225":"Transfusion-Associated Graft-Versus-Host Disease in Two Patients at Yangon General Hospital","subitem_1551255648112":""}]},"item_1583103085720":{"attribute_name":"Description","attribute_value_mlt":[{"interim":"
Transfusion-associated graft-versus-host disease (TA-GVHD) is a rare complication of blood transfusion. Two male patients admitted to the Department of Clinical Haematology, Yangon General Hospital (YGH) diagnosed to have TA-GVHD in 2011 and in 2016
\nare presented. Both of the patients received blood donation from close relatives where neither leukoreduction nor irradiation was done. Both patients had fever, skin rashes,gastrointestinal symptoms, raised liver enzymes and pancytopenia. Skin biopsies of both
\npatients showed characteristic histological changes. Unlike graft-versus-host disease that occurred after haemopoeitic stem cell transplantation, TA-GVHD involves the recipient’s bone marrow leading to bone marrow aplasia